Connect with us


Why Sen. Bernie Sanders claims with new $373K cancer drug Gilead is ‘once again gouging Americans’



The Brooklyn-born socialist, who challenged Hillary R. Clinton for the 2016 Democratic presidential nomination all the way to the convention, called out the pharmaceutical company Gilead in an  Oct. 19 statement.

“Gilead, one of the greediest pharmaceutical corporations in the world, is once again gouging Americans dealing with a life-threatening illness,” said Sen. Bernie Sander (I-Vt.), after he learned that the company was charging $373,000 for its cancer drug Yescarta. The drug was developed by Kite, the Santa Monica, California-based Gilead subsidiary.

Sanders said he was further incensed that Gilead would charge so much for a drug developed with financial support from the federal government.

Trending: The Attorney General on His Way Out?: Trump Mulls Firing Bill Barr, Advisers Trying to Dissuade Him

“This time, Gilead plans to charge an outrageous $373,000 per patient for a life-saving cancer drug developed with taxpayer money,” he said.

take our poll - story continues below

Did Kyle Rittenhouse act in self defense?

  • VOTE NOW: Did Kyle Rittenhouse act in self defense when he shot three BLM rioters? 

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to Big League Politics updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

“What good does a breakthrough medication do if no one can afford it? No one in America should die because they cannot afford the cost of the medication they need, yet that is exactly what will happen if we continue to allow Gilead and other pharmaceutical corporations to charge whatever price they want,” he said.

The Vermont senator, who switched his registration from Democrat back to Independent after the 2016 election said President Donald J. Trump needs to get involved.

““The pharmaceutical industry’s greed must end. It’s time for Congress and President Trump – who has spoken often about drugmakers ‘getting away with murder’ – to take action to lower the cost of prescription drugs in America,” he said.

Dr. Arie Belldegrun, the founder of Kite, said the FDA approval of  Yescarta was a landmark for patients with relapsed or refractory large B-cell lymphoma.

“This approval would not have been possible without the courageous commitment of patients and clinicians, as well as the ongoing dedication of Kite’s employees,” said Belldegrun, a fellow of the American College of Surgeons.

“We must also recognize the FDA for their ability to embrace and support transformational new technologies that treat life-threatening illnesses,” he said. The company plans to manufacture Yescarta in Kite’s commercial manufacturing facility in El Segundo, California.


ANOTHER PHONY? Sen. Josh Hawley Does Nothing to Oppose Big Tech Visa Giveaway for Indian Nationals

Hawley’s silence is deafening.



Yesterday, Sen. Mike Lee (R-UT) was able to pass S. 386 with unanimous consent in the Senate. The legislation is a green card giveaway lobbied for by Big Tech that will flood America with cheap Indian labor and displace native workers.

Lee has been exposed as a lawmaker who is in the back pocket of Silicon Valley monopolists at war with the Bill of Rights and Constitution:

While it is expected that Lee would completely sell America out, the silence from his colleagues who have claimed to vehemently oppose Big Tech has been far more suspicious. The unwillingness of Sen. Josh Hawley (R-MO) to oppose the measure has caused him to lose credibility among the populist “America First” base.

Big League Politics reported on how not one GOP senator had the courage to offer opposition to Lee’s big government giveaway to third-world foreigners at the behest of tech corporations who hate free speech:

Utah Senator Mike Lee succeeded in passing legislation in the Senate that would eliminate per-country-caps on recipients of H-1B visas on Wednesday, a policy change that would effectively monopolize the visa system for nationals of large countries such as India.

The Fairness for High-Skilled Immigrants Act has been called the greatest corporate welfare program for Big Tech in recent memory. Lee has persistently sought to pass the corporate giveaway, with previous attempts to eliminate per-country-caps being blocked by Democrat Dick Durbin and Republican Rick Scott. Neither Senator objected to the unanimous passage of the modified S386 legislation on Wednesday afternoon.

Big Tech monopolies such as Apple, Google and Microsoft have fervently lobbied in favor of eliminating per-country caps, seeking to replace their American workforces with de facto indentured workers who accept lower wages and worse working conditions. The pervasive use of the H-1B visa in the American technology industry has displaced countless American workers from their careers.

Lee’s giveaway doesn’t specifically raise annual H-1B visa rates, although an increase in numbers of visa workers would be a likely consequence of its enactment. It’s expected that the program will be dominated by Indian nationals in the event that Lee’s HR1044/S386 is signed into law, providing massive corporations with a considerable labor pool willing to work for less in return for an American visa.

The legislation was most recently updated with a provision blocking Chinese nationals from using the H-1B program. This provision appears to have been instrumental in securing its passage through the Senate.

It appears that Hawley is attempting to co-opt President Trump’s movement without offering much of anything in terms of real substance.

Continue Reading
It's time to name Antifa a terror org! Sign your petition now!